A Deutsche Bank survey is asking investors what they're looking for on July 9, when a pause on the so-called reciprocal ...

Privately run businesses reduced jobs in June for the first time in more than two years, as ongoing U..S. trade wars created a “hesitancy to hire and a reluctance to replace departing workers,” the ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

CytoSorbents plans to ask Canadian health authorities to reconsider rejecting the company's license application for DrugSorb-ATR, an investigational device designed to reduce the severity of bleeding ...

BrightView Holdings shares declined 8.8% in premarket trading following lowered guidance for fiscal 2025. Shares were trading around $15.37. The stock is up 5.4% on the year.

Organon will discontinue its OG-6219 clinical-development program, after the investigational candidate failed to meet its primary efficacy endpoint in treating endometriosis-related pain.